These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24471523)

  • 1. Antibiotic treatments and microbes in the gut.
    Macfarlane S
    Environ Microbiol; 2014 Apr; 16(4):919-24. PubMed ID: 24471523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic perturbation of the preterm infant gut microbiome and resistome.
    Gasparrini AJ; Crofts TS; Gibson MK; Tarr PI; Warner BB; Dantas G
    Gut Microbes; 2016 Sep; 7(5):443-9. PubMed ID: 27472377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the normal gut microbiota.
    Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
    World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Resistance and Microbiota Response.
    Santacroce L; Di Domenico M; Montagnani M; Jirillo E
    Curr Pharm Des; 2023; 29(5):356-364. PubMed ID: 36537602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective.
    Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R
    Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans.
    Wang ZJ; Chen XF; Zhang ZX; Li YC; Deng J; Tu J; Song ZQ; Zou QH
    Microb Pathog; 2017 Aug; 109():156-161. PubMed ID: 28552806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Antibiotic Resistance Genes among Human Gut-Derived Bifidobacteria.
    Duranti S; Lugli GA; Mancabelli L; Turroni F; Milani C; Mangifesta M; Ferrario C; Anzalone R; Viappiani A; van Sinderen D; Ventura M
    Appl Environ Microbiol; 2017 Feb; 83(3):. PubMed ID: 27864179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health.
    Ceapa C; Wopereis H; Rezaïki L; Kleerebezem M; Knol J; Oozeer R
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):139-55. PubMed ID: 23768559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Functional Potential of the Gut Microbiome Following Probiotic Supplementation during Helicobacter Pylori Treatment.
    Oh B; Kim JW; Kim BS
    Helicobacter; 2016 Dec; 21(6):493-503. PubMed ID: 26991862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.